Summary
42 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- It earns 13 USD a year on every 100 USD of invested capital.
- It has raised its dividend 6 years in a row.
What to watch
- The company made a loss over the last 12 months.
- Repaying its net debt would take 4.4 years of operating profit.
- Revenue fell by 2.9% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 0.3% a year over 5 years. Over the last 3 years it fell by 2.9% a year. For the next fiscal year analysts expect revenue to fall by 3.0%.
Growth in detailDoes it make money?
ReasonablyOver the last 12 months it made a loss of $894.8M.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 8.8 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 6.94%
- Raised in a row
- 6 years
You receive $2.44 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Neutral- Buy 8
- Hold 22
- Sell 6
Today's price within the analysts' price targets
The average target of $36 is 4.8% above today's price. 22% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2026By product
- Snacks 22%
- Cereal 17%
- Convenient meals 16%
- Pet 15%
- Dough 13%
- Other 17%
By region
- North America Retail Segment 83%
- North America Foodservice Segment 17%
Snacks brings in 22% of revenue.
Segments in detail